Literature DB >> 508486

An animal model for the investigation of adverse responses to i.v. anesthetic agents and their solvents.

J B Glen, G E Davies, D S Thomson, S C Scarth, A V Thompson.   

Abstract

In man the number of adverse responses to the Cremophor-containing anaesthetic agents Althesin and propanidid (Epontol) has been reported to be greater than that encountered with thiopentone. The response of the mini-pig to repeated injection of a range of i.v. anaesthetics and their solvents has been investigated in an attempt to ascertain the possible role of Cremophor in the production of these responses. A second injection of Cremophor EL or the Cremophor/Micellophor-containing agents Althesin and propanidid (Epontol), given 7 days after the first, produced a high frequency of adverse responses. On only one occasion, when alphaxalone and alphadolone were given in a mixture of alcohol and propylene glycol, was an abnormal response seen on the first administration of any agent. The second administration of alphaxalone and alphadolone in the same solvent produced abnormal responses in two of four pigs. No such responses were seen when propanidid was administered in alcohol and propylene glycol or when this solvent mixture was given alone. No abnormal responses were seen following the repeated administration of thiopentone. A marked increase in arterial pressure, and an immediate but transient marked decrease in the numbers of circulating polymorphonuclear leucocytes, were consistent findings in animals showing adverse responses. No abnormal responses were found when the interval between two administrations of Althesin was extended to 3 weeks.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 508486     DOI: 10.1093/bja/51.9.819

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  12 in total

1.  Mechanisms of hypersensitivity to intravenous agents.

Authors:  J Watkins
Journal:  Vet Res Commun       Date:  1983-12       Impact factor: 2.459

2.  Suspected anaphylactic reaction to Cremophor EL.

Authors:  D Dye; J Watkins
Journal:  Br Med J       Date:  1980-06-07

3.  Immunological and non-immunological mechanisms involved in adverse reactions to drugs.

Authors:  J Watkins; J A Thornton
Journal:  Klin Wochenschr       Date:  1982-09-01

4.  Epidemiology of adverse reactions in anaesthesia in the United Kingdom.

Authors:  R S Clarke
Journal:  Klin Wochenschr       Date:  1982-09-01

5.  Histamine release and hypotensive reactions in dogs by solubilizing agents and fatty acids: analysis of various components in cremophor El and development of a compound with reduced toxicity.

Authors:  W Lorenz; A Schmal; H Schult; S Lang; C Ohmann; D Weber; B Kapp; L Lüben; A Doenicke
Journal:  Agents Actions       Date:  1982-04

Review 6.  New drugs--boon or bane? Premedication and intravenous induction agents.

Authors:  R S Clarke
Journal:  Can Anaesth Soc J       Date:  1983-03

7.  Histamine-releasing properties of Polysorbate 80 in vitro and in vivo: correlation with its hypotensive action in the dog.

Authors:  E Masini; J Planchenault; F Pezziardi; P Gautier; J P Gagnol
Journal:  Agents Actions       Date:  1985-09

8.  The effects of cremophor EL in the anaesthetized dog.

Authors:  J H Gaudy; J F Sicard; F Lhoste; J F Boitier
Journal:  Can J Anaesth       Date:  1987-03       Impact factor: 5.063

9.  Biodistribution of O6-benzylguanine and its effectiveness against human brain tumor xenografts when given in polyethylene glycol or cremophor-EL.

Authors:  M E Dolan; A E Pegg; R C Moschel; B R Vishnuvajjala; K P Flora; M R Grever; H S Friedman
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 10.  Adverse effects of intravenously administered drugs used in anaesthetic practice.

Authors:  R S Clarke
Journal:  Drugs       Date:  1981-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.